Drugs / anhydrovinblastine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00003882 | Mar 1999 → Apr 2000 | cancer of unknown primary site | Roswell Park Cancer Institute | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | anhydrovinblastine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00003882 ↗ |
| Route | Intravenous | “Patients receive anhydrovinblastine IV over 1 hour on day 1.” NCT00003882 ↗ |